See more : Bangchak Sriracha Public Company Limited (BSRC.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hunan Hansen Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- 8×8, Inc. (EGHT) Income Statement Analysis – Financial Results
- The Straits Trading Company Limited (STTSY) Income Statement Analysis – Financial Results
- Five9, Inc. (FIVN) Income Statement Analysis – Financial Results
- Easun Reyrolle Limited (EASUNREYRL.NS) Income Statement Analysis – Financial Results
- Yeahka Limited (YHEKF) Income Statement Analysis – Financial Results
Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.hansenzy.com
About Hunan Hansen Pharmaceutical Co., Ltd.
Hunan Hansen Pharmaceutical Co., Ltd. produces and sells Chinese and chemical medicine preparations in China and internationally. It provides medicines in injection, oral liquid, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. The company is based in Yiyang, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 955.53M | 916.06M | 891.84M | 741.24M | 887.49M | 921.95M | 829.94M | 798.47M | 781.13M | 737.42M | 584.93M | 489.46M | 400.79M | 343.42M | 283.21M | 235.69M | 166.94M | 126.75M |
| Cost of Revenue | 262.78M | 255.90M | 245.86M | 220.12M | 232.40M | 236.74M | 224.99M | 230.31M | 225.92M | 212.04M | 151.77M | 122.62M | 96.15M | 80.66M | 67.29M | 57.77M | 44.34M | 36.96M |
| Gross Profit | 692.75M | 660.16M | 645.98M | 521.11M | 655.09M | 685.21M | 604.95M | 568.15M | 555.21M | 525.38M | 433.16M | 366.84M | 304.63M | 262.76M | 215.92M | 177.92M | 122.60M | 89.79M |
| Gross Profit Ratio | 72.50% | 72.07% | 72.43% | 70.30% | 73.81% | 74.32% | 72.89% | 71.16% | 71.08% | 71.25% | 74.05% | 74.95% | 76.01% | 76.51% | 76.24% | 75.49% | 73.44% | 70.84% |
| Research & Development | 44.48M | 47.90M | 39.45M | 31.23M | 33.45M | 36.44M | 50.78M | 47.85M | 52.41M | 27.23M | 20.04M | 7.37M | 4.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 23.59M | 18.24M | 14.50M | -24.59M | -30.83M | -32.31M | -55.39M | -51.41M | -49.90M | 14.94M | 23.09M | 13.00M | 8.59M | 33.68M | 19.98M | 19.91M | 13.11M | 13.65M |
| Selling & Marketing | 292.96M | 396.03M | 401.26M | 334.01M | 362.65M | 428.85M | 382.59M | 380.89M | 354.91M | 308.99M | 244.89M | 244.81M | 217.39M | 164.81M | 129.30M | 99.64M | 59.66M | 47.73M |
| SG&A | 451.77M | 414.28M | 415.75M | 309.42M | 331.82M | 396.54M | 327.20M | 329.48M | 305.01M | 323.92M | 267.98M | 257.81M | 225.98M | 198.49M | 149.29M | 119.54M | 72.76M | 61.38M |
| Other Expenses | -43.18M | 56.99M | 60.87M | 83.22M | 94.01M | -344.77K | -3.46M | 4.55M | 3.15M | 1.64M | 1.98M | -13.79M | -13.22M | 6.27M | 4.18M | 4.72M | 18.25M | 372.93K |
| Operating Expenses | 457.82M | 519.17M | 516.07M | 423.87M | 459.29M | 534.71M | 473.84M | 472.65M | 447.30M | 393.91M | 315.69M | 287.89M | 249.76M | 204.03M | 153.66M | 123.08M | 75.09M | 63.06M |
| Cost & Expenses | 720.59M | 775.07M | 761.93M | 644.00M | 691.69M | 771.45M | 698.83M | 702.96M | 673.21M | 605.95M | 467.45M | 410.51M | 345.92M | 284.69M | 220.95M | 180.86M | 119.43M | 100.02M |
| Interest Income | 1.97M | 914.66K | 687.39K | 1.08M | 501.65K | 538.17K | 717.20K | 2.55M | 3.54M | 4.38M | 12.38M | 17.02M | 17.24M | 10.26M | 682.90K | 415.21K | -0.36 | -0.18 |
| Interest Expense | 3.89M | 3.91M | 6.52M | 7.28M | 9.98M | 13.37M | 15.31M | 3.38M | 1.66M | 2.89M | 349.59K | 561.80K | 2.82M | 1.28M | 3.68M | 4.37M | 7.74M | 6.63M |
| Depreciation & Amortization | 51.68M | 52.30M | 51.70M | 50.61M | 48.32M | 46.25M | 44.47M | 42.37M | 39.24M | 35.39M | 9.80M | 8.75M | 8.55M | 7.91M | 7.67M | 6.98M | 5.27M | 9.79M |
| EBITDA | 280.66M | 147.74M | 207.61M | 174.95M | 243.69M | 202.29M | 181.47M | 133.81M | 151.70M | 170.68M | 141.83M | 105.52M | 81.36M | 82.35M | 70.93M | 62.44M | 68.12M | 28.48M |
| EBITDA Ratio | 29.37% | 30.34% | 27.92% | 27.05% | 32.92% | 24.27% | 21.45% | 17.37% | 19.89% | 23.54% | 24.26% | 21.88% | 20.30% | 24.16% | 25.25% | 26.62% | 31.69% | 22.47% |
| Operating Income | 234.94M | 188.79M | 150.27M | 117.87M | 184.96M | 159.46M | 120.03M | 84.40M | 105.97M | 129.95M | 129.08M | 93.88M | 68.59M | 66.82M | 58.54M | 50.45M | 42.13M | 18.69M |
| Operating Income Ratio | 24.59% | 20.61% | 16.85% | 15.90% | 20.84% | 17.30% | 14.46% | 10.57% | 13.57% | 17.62% | 22.07% | 19.18% | 17.11% | 19.46% | 20.67% | 21.40% | 25.24% | 14.74% |
| Total Other Income/Expenses | -8.92M | -6.94M | -370.81K | -1.56M | 1.15M | -344.77K | -9.39M | -6.65M | 11.40M | 2.45M | 1.83M | 2.42M | 952.41K | 15.25M | -2.10M | -3.44M | 12.99M | 372.93K |
| Income Before Tax | 226.02M | 181.85M | 149.90M | 116.31M | 186.10M | 159.12M | 116.58M | 88.62M | 110.80M | 132.40M | 130.91M | 96.29M | 69.55M | 73.09M | 59.58M | 51.09M | 60.38M | 19.06M |
| Income Before Tax Ratio | 23.65% | 19.85% | 16.81% | 15.69% | 20.97% | 17.26% | 14.05% | 11.10% | 14.19% | 17.95% | 22.38% | 19.67% | 17.35% | 21.28% | 21.04% | 21.68% | 36.17% | 15.04% |
| Income Tax Expense | 21.00M | 14.24M | 15.05M | 11.49M | 26.41M | 18.35M | 18.43M | 14.46M | 17.07M | 20.10M | 19.79M | 14.83M | 10.72M | 11.07M | 10.33M | 8.60M | 20.42M | 6.51M |
| Net Income | 205.01M | 167.62M | 134.85M | 106.15M | 159.70M | 140.76M | 98.14M | 71.49M | 92.66M | 111.80M | 110.83M | 81.46M | 58.83M | 62.02M | 49.25M | 42.49M | 37.87M | 11.25M |
| Net Income Ratio | 21.46% | 18.30% | 15.12% | 14.32% | 17.99% | 15.27% | 11.83% | 8.95% | 11.86% | 15.16% | 18.95% | 16.64% | 14.68% | 18.06% | 17.39% | 18.03% | 22.69% | 8.87% |
| EPS | 0.41 | 0.33 | 0.27 | 0.21 | 0.32 | 0.28 | 0.20 | 0.15 | 0.18 | 0.22 | 0.22 | 0.16 | 0.12 | 0.14 | 0.13 | 0.11 | 0.10 | 0.03 |
| EPS Diluted | 0.41 | 0.33 | 0.27 | 0.21 | 0.32 | 0.28 | 0.20 | 0.15 | 0.18 | 0.22 | 0.22 | 0.16 | 0.12 | 0.14 | 0.13 | 0.11 | 0.10 | 0.03 |
| Weighted Avg Shares Out | 503.20M | 503.20M | 503.20M | 503.20M | 503.20M | 503.20M | 503.14M | 503.13M | 503.20M | 503.16M | 503.25M | 503.46M | 500.03M | 448.66M | 372.11M | 375.28M | 373.25M | 382.44M |
| Weighted Avg Shares Out (Dil) | 503.20M | 503.20M | 503.20M | 503.20M | 503.20M | 503.27M | 503.14M | 503.13M | 503.24M | 503.20M | 503.25M | 503.57M | 500.03M | 448.66M | 372.11M | 375.28M | 373.25M | 382.44M |
No news found for: 002412.SZ
Source: https://incomestatements.info
Category: Stock Reports